Margarita Donica - Merck & Co. | 人才画像

基本信息

浏览量：23

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 12 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase II Study (KAMELEON) of Single‐agent T‐DM1 in Patients with HER2‐positive Advanced Urothelial Bladder Cancer or Pancreatic Cancer/cholangiocarcinoma

Elisabeth G. E. de Vries,Josef Rueschoff,Martijn Lolkema,Josep Tabernero,Luca Gianni,Emile Voest,Derk Jan A. de Groot,Daniel Castellano,Gilles Erb, Julia Naab,Margarita Donica,Regula Deurloo,Michiel S. van Der Heijden,Giuseppe Viale

CANCER MEDICINE（2023）

引用3浏览0WOS引用

Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma

Roland Buhl,Stephanie Korn,Andrew Menzies-Gow,Michel Aubier,Kenneth R. Chapman,Giorgio W. Canonica,Cesar Picado,Margarita Donica,Klaus Kuhlbusch,Stephan Korom,Nicola A. Hanania

The Journal of Allergy and Clinical Immunology In Practiceno. 8 (2020): 2630-2639.e6

引用16浏览0WOS引用

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1

Filippo Montemurro,Paul Ellis,Antonio Anton,Rachel Wuerstlein,Suzette Delaloge,Jacques Bonneterre,Nathalie Quenel-Tueux,Sabine C Linn,Natsumi Irahara,Margarita Donica,Nicolas Lindegger,Carlos H Barrios

European Journal of Cancer（2019）

引用76浏览0WOS引用

Primary Results from CECILIA, a Global Single-Arm Phase II Study Evaluating Bevacizumab, Carboplatin and Paclitaxel for Advanced Cervical Cancer

Andres Redondo,Nicoletta Colombo,Mary McCormack,Lydia Dreosti,Angelica Nogueira-Rodrigues,Giovanni Scambia,Domenica Lorusso,Florence Joly,Michael Schenker, Paul Ruff, Maria Estevez-Diz, Natsumi Irahara,Margarita Donica, Antonio Gonzalez-Martin

Annals of Oncology（2019）

引用3浏览0WOS引用

Outcome According to Residual Disease (surgeon's Report Vs Pre-Chemotherapy Imaging) in Patients with Bevacizumab-Treated Ovarian Cancer: Analysis of the ROSiA Study

Jacob Korach,Nicoletta Colombo,Cesar Mendiola,Frederic Selle,Ignacio Dolado,Margarita Donica,Amit M. Oza

Journal of surgical oncology（2019）

引用4浏览0WOS引用

Preliminary Results from CECILIA, an Open-Label Global Safety Study of Bevacizumab (BEV), Carboplatin (C) and Paclitaxel (P) Therapy for Metastatic, Recurrent or Persistent Cervical Cancer (CC)

Andres Redondo,Nicoletta Colombo,Lydia Mary Dreosti,Mary McCormack,Angelica Nogueira Rodrigues,Margarita Donica,Leilani Morales,Antonio Gonzalez-Martin

Journal of clinical oncology（2018）

引用6浏览0引用

Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients with Advanced Non-Small Cell Lung Cancer the AvaALL Randomized Clinical Trial

Cesare Gridelli,Javier de Castro Carpeno,Anne-Marie C. Dingemans,Frank Griesinger,Francesco Grossi,Corey Langer,Yuichiro Ohe,Konstantinos Syrigos,Nick Thatcher,Ashis Das-Gupta,Matt Truman,Margarita Donica,Vlatka Smoljanovic,Jaafar Bennouna

JAMA Oncology（2018）

引用26浏览0WOS引用

Efficacy and Safety Results from AvaALL: an Open-Label, Randomized Phase III Trial of Standard of Care (SOC) with or Without Continuous Bevacizumab (bev) Treatment Beyond Progression (PD) in Patients (pts) with Advanced Non-Small Cell Lung Cancer (NSCLC) Progressing after First-Line Bev and Chemotherapy (Chemo)

Grossi,Corey J. Langer,Yuichiro Ohe,Konstantinos N. Syrigos,Nick Thatcher,Ashis Das-Gupta,Margarita Donica,Vlatka Smoljanovic,Cesare Gridelli

JOURNAL OF CLINICAL ONCOLOGY（2017）

引用8浏览0引用

The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma

Roland Buhl,Stephanie Korn,Andrew Menzies-Gow,Michel Aubier, Ken Chapman,Giorgio Walter Canonica,César Picado,Margarita Donica,Peter Button,Klaus Kuhlbusch,Stephan Korom,Nicola A. Hanania

EUROPEAN RESPIRATORY JOURNAL（2017）

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn